cas 67139-22-4|| where to buy 5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidine

Nombre del producto:5,6,7,8-tetrahydroimidazo[1,2-a]pyrimidine

IUPAC Name:5H,6H,7H,8H-imidazo[1,2-a]pyrimidine

Unidad de embalaje	Stock disponible	Precio($)
CM129212-250mg	in stock	ƋȦ
CM129212-1g	in stock	ƱɐǕ
CM129212-5g	in stock	Ȍɐȷ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 67139-22-4 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :67139-22-4; Fórmula molecular:C6H9N3; Punto de fusión:-; Código de sonrisas:C12=NC=CN1CCCN2; Densidad:

: Número de catálogo:CM129212; Peso molecular:123.16; Punto de ebullición:277.1°C at 760 mmHg; Nº Mdl:MFCD08273903; Almacenamiento:Store at 2-8°C.

: Imidazoles; Imidazole is an important five-membered nitrogen-containing heterocyclic compound. Among the numerous heterocyclic compounds, imidazole and its derivatives are regarded as a unique and multifaceted scaffold material due to their diverse applications in industrial, organic and pharmaceutical chemistry. Imidazoles interact in different ways with many therapeutic targets, enzymes and receptors in biological systems and thus exhibit a wide range of biological activities. In particular, several imidazoles can be used as clinical drugs to treat various types of cancer with high therapeutic efficacy. Furthermore, imidazoles are one of the most critical segments in the field of anti-covid-19 virus drug discovery due to their ability to interact with active targets in living systems.; Imidazole Manufacturer; As a professional imidazole manufacturer, we can guarantee product quality and delivery time.our company has been committed to supply personalized product solutions to customers,pls consult us.